Healthspan Capital is an early-stage longevity venture capital firm that invests in biotechnology startups developing therapies to slow or reverse aging.
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 19
| Date | Name | Website | Total Raised | Location |
| 12.07.2025 | Resevoir N... | reservoirneuro.com | $4M | United Sta... |
| 30.06.2025 | Immunis Bi... | immunisbiomedical.com | - | United Sta... |
| 30.06.2025 | etherospha... | etherospharma.com | - | - |
| - | Olden Labs | oldenlabs.com | - | - |
| - | Shift Bios... | shiftbioscience.com | $16.33M | United Kin... |
| - | Vincere Bi... | vincerebio.com | $5M | United Sta... |
| - | Oisín Biot... | oisinbio.com | $15M | - |
| - | Weatherwax... | weatherwax.bio | - | United Sta... |
| - | Zoe Biosci... | zoebiosciences.com | - | - |
| - | Samsara Th... | samsaratherapeutics.com | $3.2M | United Kin... |
Show more
Mentions in press and media 5
| Date | Title | Description |
| 24.03.2026 | ImmuneBridge Secures $7.7M to Open Cell Therapy Manufacturing Platform to Biotech Partners | What You Should Know The Funding & The Pivot: ImmuneBridge has secured a $7.7M second seed round (bringing its total seed funding to nearly $20M) led by NFX, with participation from One Way Ventures, M Ventures, Insight Partners, LongGa... |
| 13.10.2022 | KetoSwiss secures $4 million | |
| 13.10.2022 | KetoSwiss secures $4 million pre-seed capital | |
| 18.08.2022 | 5 investors explain why longevity tech is a long-term play | Of all the stories passed on through history, the tales of life unending have persisted in the human imagination without much change. The details differ, but nearly every civilization right from the time of the Egyptians has in some form or... |
| 18.08.2022 | These 5 investors are betting on helping you live longer and better | Analysts estimate that the market for “delaying human death” could be worth $610 billion by 2025. But that doesn’t sit well with Christian Angermayer, who co-founded Cambrian BioPharma and Rejuveneron, and whose family office Apeiron Invest... |